AbMax Biotechnology Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
36
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$2.84M
- Investors
-
1
AbMax Biotechnology General Information
Description
Developer of a one-stop antibody and kit development designed to advance biotechnology research and applications. The company offers state-of-the-art antibody humanization technologies and vaccine-specific antibody solutions, enabling researchers and vaccine developers to achieve precise testing and enhanced vaccine quality.
Contact Information
Website
www.antibodychina.comCorporate Office
- Room 201, Unit 2, Building 18, No. 99, Kechuang 14th Street, Beijing Economic and Technolo
- Number 220 Dongting Road, Tianjin Development Zone
- Beijing, 101111
- China
Corporate Office
- Room 201, Unit 2, Building 18, No. 99, Kechuang 14th Street, Beijing Economic and Technolo
- Number 220 Dongting Road, Tianjin Development Zone
- Beijing, 101111
- China
AbMax Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC (Series A) | 20-Nov-2019 | $2.84M | Completed | Generating Revenue |
AbMax Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
AbMax Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
AbMax Biotechnology Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amphora Capital China | Venture Capital | Minority |
AbMax Biotechnology FAQs
-
When was AbMax Biotechnology founded?
AbMax Biotechnology was founded in 2006.
-
Where is AbMax Biotechnology headquartered?
AbMax Biotechnology is headquartered in Beijing, China.
-
What is the size of AbMax Biotechnology?
AbMax Biotechnology has 36 total employees.
-
What industry is AbMax Biotechnology in?
AbMax Biotechnology’s primary industry is Biotechnology.
-
Is AbMax Biotechnology a private or public company?
AbMax Biotechnology is a Private company.
-
What is AbMax Biotechnology’s current revenue?
The current revenue for AbMax Biotechnology is .
-
How much funding has AbMax Biotechnology raised over time?
AbMax Biotechnology has raised $2.84M.
-
Who are AbMax Biotechnology’s investors?
Amphora Capital China has invested in AbMax Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
